KIT and gastrointestinal stromal tumor: GISTs themselves could only be reliably distinguished from other histopathological subtypes with the discovery of gain-of-function mutations in the c-KIT proto-oncogene in 1998, which is why our evaluation of GIST included fewer time periods [16].